Uptake and Usage Patterns of Biosimilar Infliximab in the Medicare Population
- 23 June 2020
- journal article
- letter
- Published by Springer Nature in Journal of General Internal Medicine
- Vol. 36 (7) , 2170-2173
Abstract
No abstract availableThis publication has 3 references indexed in Scilit:
- US FDA finalizes hand sanitizer ruleFocus on Surfactants, 2019
- Uptake of the Biologic Filgrastim and Its Biosimilar Product Among the Medicare PopulationJAMA, 2018
- Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity‐score matched samplesStatistics in Medicine, 2009